iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $58.53 million. The enterprise value is -$88.55 million.
| Market Cap | 58.53M |
| Enterprise Value | -88.55M |
Important Dates
The last earnings date was Tuesday, September 29, 2026, before market open.
| Earnings Date | Sep 29, 2026 |
| Ex-Dividend Date | Apr 17, 2026 |
Share Statistics
iHuman has 51.12 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.12M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -3.66% |
| Owned by Insiders (%) | 72.47% |
| Owned by Institutions (%) | 0.33% |
| Float | 14.07M |
Valuation Ratios
The trailing PE ratio is 17.14.
| PE Ratio | 17.14 |
| Forward PE | n/a |
| PS Ratio | 0.53 |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | 8.44 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.91 |
| Quick Ratio | 2.60 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 0.18 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.59% and return on invested capital (ROIC) is -0.40%.
| Return on Equity (ROE) | 2.59% |
| Return on Assets (ROA) | -0.28% |
| Return on Invested Capital (ROIC) | -0.40% |
| Return on Capital Employed (ROCE) | -0.70% |
| Weighted Average Cost of Capital (WACC) | 4.16% |
| Revenue Per Employee | $196,309 |
| Profits Per Employee | $6,154 |
| Employee Count | 558 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 9.16 |
Taxes
In the past 12 months, iHuman has paid $142,062 in taxes.
| Income Tax | 142,062 |
| Effective Tax Rate | 3.97% |
Stock Price Statistics
The stock price has decreased by -58.51% in the last 52 weeks. The beta is -0.00, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -58.51% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 42.20 |
| Average Volume (20 Days) | 4,652 |
Short Selling Information
The latest short interest is 1,101, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 1,101 |
| Short Previous Month | 3,239 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, iHuman had revenue of $109.54 million and earned $3.43 million in profits. Earnings per share was $0.07.
| Revenue | 109.54M |
| Gross Profit | 73.12M |
| Operating Income | -861,795 |
| Pretax Income | 3.58M |
| Net Income | 3.43M |
| EBITDA | -156,268 |
| EBIT | -861,795 |
| Earnings Per Share (EPS) | $0.07 |
Balance Sheet
The company has $148.30 million in cash and $1.23 million in debt, with a net cash position of $147.08 million or $2.88 per share.
| Cash & Cash Equivalents | 148.30M |
| Total Debt | 1.23M |
| Net Cash | 147.08M |
| Net Cash Per Share | $2.88 |
| Equity (Book Value) | 122.47M |
| Book Value Per Share | 2.40 |
| Working Capital | 113.98M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -732,655 |
| Depreciation & Amortization | 716,143 |
| Net Borrowing | n/a |
| Free Cash Flow | 6.94M |
| FCF Per Share | $0.14 |
Margins
Gross margin is 66.75%, with operating and profit margins of -0.79% and 3.13%.
| Gross Margin | 66.75% |
| Operating Margin | -0.79% |
| Pretax Margin | 3.26% |
| Profit Margin | 3.13% |
| EBITDA Margin | -0.14% |
| EBIT Margin | -0.79% |
| FCF Margin | 5.96% |
Dividends & Yields
This stock pays an annual dividend of $0.10, which amounts to a dividend yield of 8.73%.
| Dividend Per Share | $0.10 |
| Dividend Yield | 8.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 127.22% |
| FCF Payout Ratio | 62.77% |
| Buyback Yield | 0.58% |
| Shareholder Yield | 9.31% |
| Earnings Yield | 5.87% |
| FCF Yield | 11.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iHuman has an Altman Z-Score of 2.46 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.46 |
| Piotroski F-Score | 1 |